Piper Jaffray Jumps On Human Genome Sciences (HGSI) Bandwagon, Upgrades to Buy
Tweet Send to a Friend
Piper Jaffray upgrades Human Genome Sciences (Nasdaq: HGSI) from Neutral to Overweight and raised its price target from $1.70 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
